Cover Image
Market Research Report
Product code 
965964

Global Enteral Feeding Formulas Market, Size, Share, Opportunities and Forecast, 2020-2027

Published: | DataM Intelligence | 180 Pages | Delivery time: 2 business days

Price

Back to Top
Global Enteral Feeding Formulas Market, Size, Share, Opportunities and Forecast, 2020-2027
Published: April 3, 2021
DataM Intelligence
Content info: 180 Pages
Delivery time: 2 business days
  • ALL
  • Description
  • Table of Contents
Description

Global Enteral Feeding Formulas Market is segmented By Product (Disease-specific Formulas (Pulmonary Formulas, Diabetic Formulas, Hepatic Formulas, Renal Formulas, Others), Standard Formulas (Monomeric Formulas, Polymeric Formulas)), By Stage (Adults, Pediatrics), By Flow Type (Intermittent Feeding Flow, Continuous Feeding Flow), By Application (Oncology, Diabetes, Neurology, Gastroenterology, Critical Care, Others), By End-User (Hospitals, Homecare Agencies & Hospices, Long-term Care Facilities, Nursing Homes, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Share, Size, Outlook, and Opportunity Analysis, 2020-2027

Market Overview

The Global Enteral Feeding Formulas Market is expected to grow at a high CAGR of 6.8% during the forecasting period (2020-2027).

Enteral feeding is delivery of a nutritionally complete feed containing fat, protein, minerals, carbohydrate, water, and vitamins, directly to stomach, duodenum, or jejunum. There are various types of tubes available for enteral feed formula, such as, gastrostomy, nasojejunal tube, nasogastric tube and jejunostomy. These tubes are made of silicon, polyurethane or PVC and are of different length from 30 to 43 inches, with diameters from 8 to 14 inches for adults. Some of the other equipment used for enteral feeding include, administration reservoir (bottle, feed bag, etc.), syringes, and enteral pump. Various routes are used in the administration of the necessary nutrients are cost-effective, healthy and also an alternative choice for the invasive process. Enteral feeding  is preferred for patients with malnutrition due to eating disorders such as anorexia nervosa, dysphagia, and stomach infections, among others.

Source: DataM Intelligence Analysis (2019)

Market Dynamics

The demand for enteral feeding formula demand is surging with rising therapeutic uses of enteral feeding formula coupled with the introduction of new technologically advanced enteral feeding formula. In addition, the growing geriatric population globally and the rising prevalence of preterm births are also boosting the market growth.

High prevalence rate of chronic disorders is dirving the market growth

Increasing incidences of chronic disorders, such as cardiovascular diseases, cancer, diabetes, and (Coronary Obstructive Pulmonary Disorders) COPD is expected to drive the growth of the enteral feeding formulas market.

As per the International Diabetes Federation, diabetes patients spent US$ 760 billion in 2019, of which, most was spent by Type-1 diabetes patients on insulin drugs. Around 463 million adults (20-79 years) are living with diabetes currently, and by 2045 this is projected to rise to 700 million. The proportion of type 2 diabetes people is increasing in most countries.

Also, as per the American Heart Association, in 2015, approximately 41.5% of the U.S. population was suffering from some form of cardiac disease, it is further estimated that this prevalence is likely to increase to 45% by 2035. According to the Centers for Disease Control and Prevention (CDC) of the U.S., about half of the population (47%) of the United States have at least one of these three risk factors.

For the treatment of these chronic diseases, a longer hospital stay and recovery time is required. Patients face problems in swallowing food, so, external nutrition is given to the patient through the tube. Hence, the increase in the cases of chronic diseases, such as cancer and cardiovascular diseases, are expected to drive the growth of the market over the forecast period.

Lack of reimburesement is hampering the growth of the enteral feeding formulas market

The lack of reimbursement of enteral feeding formula is expected to hamper the usage of enteral feeding formula and lower the adoption rate of the enteral feeding formula in the forecast period.

COVID-19 Impact Analysis

The demand for enteral feeding formulas is growing with the increasing number of COVID-19 cases in hospitals. In 2020, the critical care segment is rapidly growing in the enteral feeding formula industry due to the rising number of the COVID-19 patients, which are also leading the consumption of nutritional feeding formulas more towards the patients with the ventilators.

With growing awareness among the healthcare professionals regarding hospital-associated malnutrition is anticipated to boost the usage rate of enteral feeding formulas in hospitals. Moreover, increasing number of ICU admissions during COVID-19, rising demand for enteral formulations among critically ill patients, is likely to boost the market growth.

Segment Analysis

The global enteral feeding formulas market is segmented on the basis of product, flow type, stage, application, and end-users.

Oncology segment is expected to hold a major market share in the enteral feeding formulas market

The burden of cancer is growing rapidly worldwide. Cancer is expected to grow rapidly during the forecast period. The WHO has reported that cancer is the second leading cause of death globally and is responsible for 9.6 million deaths in 2018 and worldwide, about 1 in 6 deaths is only because of cancer. Also, around 70% of deaths from cancer occur in low and middle-income countries. WHO stated that around 17.9 million people die each year with cardiovascular diseases, and globally, it accounts for 31% of deaths. Majority of tumour-bearing patients suffer from cancer cachexia, which causes insulin resistance, increased lipolysis with loss of body fat, increased protein turnover, and loss of muscle mass, causing loss of appetite and weight.

Also, there are several complications and side effects in the patients while cancer treatment, including difficulty in chewing and swallowing solid food, mucositis sores in the mouth, altered saliva level, which makes it difficult to swallow. To improve the clinical condition of patients, delivery of nutrition is very difficult for the cancer patients to take the food orally, hence, the nutrition is supplied by enteral feeding tubes to help them maintain the body mass.

Standard formulas segment is expected to hold the largest market share during the forecast period

By product, the market is classified into standard and disease-specific formulas. Among these, the standard formulas segment accounted for the largest market share due to its high demand for enteral nutrition and basic clinical nutrition, high commercial availability, and growing investment by major companies. The standard formulas segment is further segmented into polymeric formulas and monomeric formulas. There are different varieties of standard formulas available with the growing demand for low-cost nutrient formulations. The demand for standard tube feeds is high among volume sensitive patients or patients with congestive heart failure, Syndrome of Inappropriate Diuretic Hormone (SIADH), and renal failure.

On the other hand, the disease-specific formulas are expected to grow at the fastest growth rate during the forecast period, 2020 to 2027 due to growing improvements in enteral feeding formula and devices with rising prevalence of several chronic diseases. Disease-specific formulas segment is further segmented into renal, diabetic, hepatic, pulmonary, and others. With growing awareness among healthcare professionals and patient population towards the benefits of enteral medical foods is one of the major factors driving the segment growth.

By Stage, the Adult Segment held the largest market share in 2019

On the basis of stage, the market is segmented into adults and paediatrics. The adults segment accounted for the largest market share in 2019, due to the growing adoption of tube feed among adults. The enteral feeding can be performed by the syringe method, gravity drip method, and the pump method in adults. According to a study by the Medical Nutrition International Industry, the financial cost associated with malnutrition or undernutrition in the European Union is around US$ 185 billion. About one in six individuals are affected by malnutrition globally. With the growing demand for such nutrition formulations in the adult population is one of the major factors boosting segment growth.

On the other hand, the paediatrics segment is expected to grow significantly over the forecast period, due to the rising number of premature births and increasing prevalence rate of malnutrition among hospitalized children. For instance, as per the report published by UNICEF, in September 2016, around three million young individuals die due to malnutrition each year. The pediatric patients with a dysfunctional gastrointestinal tract cannot ingest nutrients orally, and thus administered enteral feeding. Some pediatric patients suffering from gastrointestinal disorders, such as severe gastroesophageal reflux, allergies, food refusal behaviour, and metabolic disorders are also provided tube feeding.

By End-user, Home care is expected to grow significantly over the forecast period.

Home care is expected to grow at the fastest growth rate over the forecast period, owing to the rising number of patients receiving home enteral feeding with growing awareness towards balanced nutrition. There is a rise in adoption of enteral feeding formulas among home healthcare patients. A policy was developed in combination with the National Institute for Clinical Excellence (NICE) which has revolutionized the healthcare service for patients on nutrition supplements and has enhanced the service delivery.

Source: DataM Intelligence Analysis (2019)

Geographical Analysis

North America region holds the largest market share in global enteral feeding formulas market

North America region is dominating the global enteral feeding formulas market accounted for the largest market share in 2019, due to several factors, such as the growing geriatric population, rising prevalence of preterm birth, and the increasing number of chronic disease patients. The United States is the major contributor to the growth of enteral feeding formulas market. In the U.S., it is projected that the number of people aged above 65 years will more than double by 2060. The growing geriatric population would increase the cases of chronic diseases, such as cancer and diabetes, which will lead to an increase in the hospital stay of the patient. Also, according to the WHO, around 15 million babies are born preterm, and this number is rising. Hence, the market is expected to grow further in this region over the forecast period.

Asia-Pacific region is growing at the fastest CAGR during the forecast period.

The Asia Pacific market is expected to grow at the fastest CAGR during the forecast period. The market in Japan, China, and India are likely to grow significantly during the forecast period, due to the large presence of patients suffering from chronic diseases and disorders, increasing incidences of preterm births, growing healthcare expenditure, rapidly developing healthcare infrastructure, and growing demand in these countries.

Competitive Landscape

The enteral feeding formulas market is highly competitive with presence of local as well as global companies.  Some of the key players which are contributing to the growth of the market include Abbott Laboratories, Fresenius Kabi AG, B. Braun Melsungen AG, Victus, Inc., Hormel Food Corp., Danone S.A., Nestle S.A., Mead Johnson Nutrition Company, Global Health Products, Inc., Meiji Holdings Co., Ltd., Trovita Health Science, among others.

B. Braun Melsungen AG

Overview:

B. Braun is majorly involved in the manufacturing, marketing and distributing various healthcare products and services in the fields of medical technology, medical services, and pharmaceutical products. The company product range comprises of around 5,000 products of which 95% of the products being manufactured by the company. Some of the major product lines manufactured by the company include disposables required for infusion, nutrition and pain therapy, infusion pumps and systems, surgical instruments, suture materials, hip and knee implants, dialysis equipment and accessories, and stoma and wound care products. B. Braun has presence in 64 countries and develops products in 18 therapy fields of the healthcare industry. The company operates its business through five business divisions which include hospital care, Aesculap, B. Braun Avitum, out-patient market (OPM) and other sales.

Product Portfolio:

Enteral Nutrition Pumps:

Enteroport® plus: Enteral nutrition pump

Accessories Enteroport® plus: Accessories for the enteral nutrition pump Enterport® plus

Feeding Tubes

Nutritub®: Polyurethane feeding tube

Gastric Tubes: Naso-gastric and naso-intestinal PVC tubes for short term use only.

Duodenal Tubes: PVC tube

Others

Key Development:

The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Enteral Feeding Formulas market globally. For instance,

In June 2020, Hormel Foods has been named to the 100 Best Corporate Citizens list by 3BL Media, recognizing outstanding environmental, social and governance (ESG) transparency and performance among the 1,000 largest U.S. public companies. This increases the credibility of the company and establishes a good name in the market

In October 2017, Real Food Blends announced the launch of New Breakfast Meal Featuring Eggs, Apples & Oats. This meal is available for the people who cannot eat orally. The launch of the product provides high nutrition profile to the consumers.

Why Purchase the Report?

Visualize the composition of the enteral feeding formulas market segmentation by product, stage, application, flow type, and end-user highlighting the key commercial assets and players.

Identify commercial opportunities in enteral feeding formulas market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of enteral feeding formulas market - level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global enteral feeding formulas market report would provide an access to an approx. 77 market data table, 73 figures and 300 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Related Topic's

Automatic Feeding System Market

UK & Ireland Automatic Feeding Systems Market

Table of Contents

Table of Contents

Table of Contents

Enteral Feeding Formulas Market Methodology and Scope

Research Methodology

Research Objective and Scope of the Report

Enteral Feeding Formulas Market - Market Definition and Overview

Enteral Feeding Formulas Market - Executive Summary

Market Snippet by Product

Market Snippet by Stage

Market Snippet by Flow Type

Market Snippet by Application

Market Snippet by End-User

Market Snippet by Region

Enteral Feeding Formulas Market-Market Dynamics

Market Impacting Factors

Drivers

Rising prevalence of chronic diseases and disorders

Growing number of preterm births

Technological advancement in feeding formulas

XX

Restraints

Complications associated with enteral feeding

XX

Opportunity

Impact Analysis

Enteral Feeding Formulas Market - Industry Analysis

Porter's Five Forces Analysis

Supply Chain Analysis

Pricing Analysis

Regulatory Analysis

Reimbursement Analysis

Unmet Needs

Enteral Feeding Formulas Market - COVID-19 Analysis

Analysis of Covid-19 on the Market

Before COVID-19 Market Scenario

Present COVID-19 Market Scenario

After COVID-19 or Future Scenario

Pricing Dynamics Amid Covid-19

Demand-Supply Spectrum

Government Initiatives Related to the Market During Pandemic

Manufacturers Strategic Initiatives

Conclusion 

Enteral Feeding Formulas Market - By Product

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment

Market Attractiveness Index, By Product Segment

Disease-specific Formulas*

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

Pulmonary Formulas

Diabetic Formulas

Hepatic Formulas

Renal Formulas

Others

Standard Formulas

Monomeric Formulas

Polymeric Formulas

Enteral Feeding Formulas Market - By Stage

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Stage

Market Attractiveness Index, By Stage Segment

Adults *

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

Pediatrics

Enteral Feeding Formulas Market - By Flow Type

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Flow Type

Market Attractiveness Index, By Flow Type Segment

Intermittent Feeding Flow*

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

Continuous Feeding Flow

Enteral Feeding Formulas Market - By Application

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment

Market Attractiveness Index, By Application Segment

Oncology*

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

Diabetes

Neurology

Gastroenterology

Critical Care

Others

Enteral Feeding Formulas Market - By End-User

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment

Market Attractiveness Index, By End-User Segment

Hospitals*

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

Homecare Agencies & Hospices

Long-term Care Facilities

Nursing Homes

Others

Enteral Feeding Formulas Market - By Region

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

Market Attractiveness Index, By Region

North America

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Stage

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Flow Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

U.S.

Canada

Mexico

Europe

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Stage

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Flow Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Germany

U.K.

France

Italy

Spain

Rest of Europe

South America

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Stage

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Flow Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Brazil

Argentina

Rest of South America

Asia Pacific

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Stage

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Flow Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

China

India

Japan

Australia

Rest of Asia Pacific

Middle East and Africa

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Flow Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Stage

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

Enteral Feeding Formulas Market - Competitive Landscape

Competitive Scenario

Market Positioning/Share Analysis

Mergers and Acquisitions Analysis

Enteral Feeding Formulas Market- Company Profiles

Abbott Laboratories*

Company Overview

Product Portfolio and Description

Key Highlights

Financial Overview

Fresenius Kabi AG

B. Braun Melsungen AG

Victus, Inc.

Danone S.A.

Nestle S.A.

Mead Johnson Nutrition Company

Health Products, Inc.

Meiji Holdings Co., Ltd.,

Trovita Health Science (List Not Exhaustive)

Enteral Feeding Formulas Market - Premium Insights

Enteral Feeding Formulas Market - DataM

Appendix

About Us and Services

Contact Us

Suggestions for Related Market Report:

Standard Enteral Feeding Formulas Market

Disease-specific Enteral Feeding Formulas Market